Fitness landscapes and the myeloid leukemiasPREISLER, H. D.Leukemia research. 1999, Vol 23, Num 2, pp 167-176, issn 0145-2126Article

Resistence to cytotoxic therapy : a speculative overviewPREISLER, H. D.Annals of oncology. 1995, Vol 6, Num 7, pp 651-657, issn 0923-7534Article

Genetic mechanisms in chronic myelogenous leukemiaPREISLER, H. D.Blood. 1990, Vol 75, Num 7, pp 1587-1588, issn 0006-4971, 2 p.Article

High-dose cytosine arabinoside therapy in acute non-lymphocytic leukemia = Traitement de la leucémie non lymphocytaire aiguë par dose élevée de cytosine arabinosidePREISLER, H. D.European journal of cancer & clinical oncology. 1984, Vol 20, Num 2, pp 297-300, issn 0277-5379Article

A new approach to the detection of DNA damageKAWAMURA, M; PREISLER, H. D.Leukemia research. 1989, Vol 13, Num 5, pp 391-398, issn 0145-2126Article

Uptake of adriamycin by human leukemic cells as measured by flow cytometry = Mesure par cytométrie à flux de la fixation de l'adriamycine par les cellules leucémiquesPREISLER, H. D; RAZA, A.Medical oncology and tumor pharmacotherapy. 1984, Vol 1, Num 1, pp 43-48, issn 0736-0118Article

In vitro drug sensitivity studies of CFU_c in chronic myelocytic leukemia: I. Suicide indices and busulfan sensitivity determinations during the chronic phasePREISLER, H. D; KIRSHNER, J.Experimental hematology. 1983, Vol 11, Num 7, pp 618-625, issn 0301-472XArticle

Differentiation of myeloid cells in liquid culture.II: Acute myelocytic leukemia cellsARCHIMBAUD, E; PREISLER, H. D.Cell biochemistry and function. 1987, Vol 5, Num 3, pp 157-166, issn 0263-6484Article

Differentiation of myeloid cells in liquid culture. I: Progenitor cells found in normal peripheral bloodARCHIMBAUD, E; PREISLER, H. D.Cell biochemistry and function. 1986, Vol 4, Num 4, pp 255-261, issn 0263-6484Article

A non-clonogenic assay for the determination of the sensitivity of leukemic cells to chemotherapeutic agents = Méthode non clonogène de détermination de la sensibilité des cellules leucémiques à la chimiothérapieEPSTEIN, J; PREISLER, H. D.European journal of cancer & clinical oncology. 1983, Vol 19, Num 11, pp 1569-1574, issn 0277-5379Article

Autologous bone marrow transplantation for acute leukaemia in remissionPREISLER, H. D; RAZA, A.British journal of haematology. 1987, Vol 65, Num 3, pp 377-379, issn 0007-1048Article

Doubler labeling of human leukemic cells using ³H-cytarabine and monoclonal antibody against bromodeoxyuridineAZRA RAZA; PREISLER, H. D.Cancer treatment reports. 1985, Vol 69, Num 2, pp 195-198, issn 0361-5960Article

Assessment of the drug sensitivity of acute nonlymphocytic leukemia using the in vitro clonogenic assayPREISLER, H. D; AZARNIA, N.British journal of haematology. 1984, Vol 58, Num 4, pp 633-640, issn 0007-1048Article

The myelodysplastic syndromes in 1996 : Complex stem cell disorders confounded by dual actions of cytokinesRAZA, A; GREGORY, S. A; PREISLER, H. D et al.Leukemia research. 1996, Vol 20, Num 11-12, pp 881-890, issn 0145-2126Article

Differences in cell cycle characteristics among patients with acute nonlymphocytic leukemiaRAZA, A; MAHESHWARI, Y; PREISLER, H. D et al.Blood. 1987, Vol 69, Num 6, pp 1647-1653, issn 0006-4971Article

Regrowth resistance in leukemia and lymphoma : the need for a new system to classify treatment failure and for new approaches to treatment. CommentaryPREISLER, H. D; GOPAL, V; ESTEY, R. H et al.Leukemia research. 1994, Vol 18, Num 3, pp 149-161, issn 0145-2126Article

Alteration of the proliferative rate of acute myelogenous leukemia cells in vivo in patientsPREISLER, H. D; RAZA, A; LARSON, R. A et al.Blood. 1992, Vol 80, Num 10, pp 2600-2603, issn 0006-4971Article

Double labeling and in vitro versus in vivo incorporation of bromodeoxyuridine in patients with acute nonlymphocytic leukemiaAZRA RAZA; KALUST UCAR; PREISLER, H. D et al.Cytometry (New York, N.Y.). 1985, Vol 6, Num 6, pp 633-640, issn 0196-4763Article

Treatment of dysmyelopoietic/leukemic syndromes with myelofibrosis and megakaryocytic hyperplasia with large doses of cytosine arabinosidePREISLER, H. D; RAZA, A; BARCOS, M et al.Medical oncology and tumor pharmacotherapy. 1985, Vol 2, Num 2, pp 87-91, issn 0736-0118Article

Predicting remission outcome in acute non-lymphocytic leukemia : general principles and their application to residual marrow leukemiaBROWMAN, G. P; PREISLER, H. D.Leukemia research. 1992, Vol 16, Num 5, pp 511-519, issn 0145-2126Article

Current problems in the treatment of acute myelocytic leukemia (AML) and some possible solutionsPREISLER, H. D; RAZA, A.Leukemia. 1992, Vol 6, pp 81-84, issn 0887-6924, SUP2Conference Paper

C-MYC detection in bone marrow biopsiesPAVELIC, K; PAVELIC, Z. P; PREISLER, H. D et al.Leukemia research. 1991, Vol 15, Num 11, pp 1075-1078, issn 0145-2126Article

Lack of relationship between in vitro cell measurements and response to busulfan in chronic myelocytic leukemiaKIRSHNER, J; PREISLER, H. D; RAZA, A et al.American journal of hematology. 1985, Vol 18, Num 2, pp 191-200, issn 0361-8609Article

Prednimustine in acute nonlymphocytic leukemia = Prednimustine dans les leucémies aiguës non lymphoïdesAYULO, M. A; PREISLER, H. D.American journal of clinical oncology. 1983, Vol 6, Num 2, pp 207-209, issn 0277-3732Article

Studies of the proliferation and differentiation of immature myeloid cells in vitro. I: Chronic myelogenous leukemiaWANG, Z; GAO, X. Z; PREISLER, H. D et al.American journal of hematology. 1989, Vol 30, Num 2, pp 77-81, issn 0361-8609Article